Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.4899
+0.0499 (11.33%)
Apr 24, 2025, 12:49 PM EDT

Pharma-Bio Serv Statistics

Total Valuation

Pharma-Bio Serv has a market cap or net worth of 10.09 million. The enterprise value is -2.19 million.

Market Cap 10.09M
Enterprise Value -2.19M

Important Dates

The next estimated earnings date is Friday, June 13, 2025.

Earnings Date Jun 13, 2025
Ex-Dividend Date Feb 28, 2025

Share Statistics

Pharma-Bio Serv has 22.93 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Current Share Class n/a
Shares Outstanding 22.93M
Shares Change (YoY) -0.17%
Shares Change (QoQ) -0.05%
Owned by Insiders (%) 54.92%
Owned by Institutions (%) 1.49%
Float 8.40M

Valuation Ratios

PE Ratio n/a
Forward PE 4.00
PS Ratio 1.05
PB Ratio 0.84
P/TBV Ratio 0.84
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 4.40
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 1.16

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.01.

Current Ratio 4.54
Quick Ratio 4.42
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.08
Interest Coverage -29.71

Financial Efficiency

Return on equity (ROE) is -3.81% and return on invested capital (ROIC) is -4.42%.

Return on Equity (ROE) -3.81%
Return on Assets (ROA) -3.33%
Return on Invested Capital (ROIC) -4.42%
Return on Capital Employed (ROCE) -7.44%
Revenue Per Employee 128,006
Profits Per Employee -6,645
Employee Count 75
Asset Turnover 0.54
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.14% in the last 52 weeks. The beta is 0.64, so Pharma-Bio Serv's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -37.14%
50-Day Moving Average 0.50
200-Day Moving Average 0.57
Relative Strength Index (RSI) 36.87
Average Volume (20 Days) 1,954

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.04

Income Statement

In the last 12 months, Pharma-Bio Serv had revenue of 9.60 million and -498,364 in losses. Loss per share was -0.02.

Revenue 9.60M
Gross Profit 2.75M
Operating Income -941,478
Pretax Income -488,026
Net Income -498,364
EBITDA -916,014
EBIT -941,478
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 12.43 million in cash and 153,994 in debt, giving a net cash position of 12.28 million or 0.54 per share.

Cash & Cash Equivalents 12.43M
Total Debt 153,994
Net Cash 12.28M
Net Cash Per Share 0.54
Equity (Book Value) 12.00M
Book Value Per Share 0.52
Working Capital 12.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.72 million and capital expenditures -158,923, giving a free cash flow of -1.88 million.

Operating Cash Flow -1.72M
Capital Expenditures -158,923
Free Cash Flow -1.88M
FCF Per Share -0.08
Full Cash Flow Statement

Margins

Gross margin is 28.63%, with operating and profit margins of -9.81% and -5.19%.

Gross Margin 28.63%
Operating Margin -9.81%
Pretax Margin -5.08%
Profit Margin -5.19%
EBITDA Margin -9.54%
EBIT Margin -9.81%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 17.05%.

Dividend Per Share 0.08
Dividend Yield 17.05%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.17%
Shareholder Yield 17.22%
Earnings Yield -4.94%
FCF Yield -18.64%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Pharma-Bio Serv has an Altman Z-Score of 4.46.

Altman Z-Score 4.46
Piotroski F-Score n/a